Parvovirus-B19-associated complications in renal transplant recipients (Q36951683)

17 August 2017

1 reference

title

Parvovirus-B19-associated complications in renal transplant recipients (English)

1 reference

17 August 2017

Jeffrey B Kopp

2

0 references

author name string

Meryl Waldman

series ordinal

1

1 reference

17 August 2017

publication date

1 October 2007

1 reference

Nature Clinical Practice Nephrology

17 August 2017

published in

1 reference

17 August 2017

volume

3

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

540-550

1 reference

Multiple Glycosphingolipids Determine the Tissue Tropism of Parvovirus B19

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

Experimental parvoviral infection in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

Antibody responses in parvovirus B19 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

Persistence of human parvovirus B19 in human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

The age-specific prevalence of human parvovirus immunity in Victoria, Australia compared with other parts of the world

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

The prevalence of antibody to human parvovirus B19 in England and Wales

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Identification and characterization of a second novel human erythrovirus variant, A6.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Genetic diversity within human erythroviruses: identification of three genotypes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Biological and immunological relations among human parvovirus B19 genotypes 1 to 3.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

A new parvovirus genotype persistent in human skin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Erythrocyte P antigen: cellular receptor for B19 parvovirus

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: requirement of functional activation of beta1 integrin for viral entry

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19 nonstructural (NS1) protein induces apoptosis in erythroid lineage cells.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Molecular and functional analyses of a human parvovirus B19 infectious clone demonstrates essential roles for NS1, VP1, and the 11-kilodalton protein in virus replication and infectivity

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19 nonstructural protein (NS1) induces cell cycle arrest at G(1) phase

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus infection in homozygous sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Advances in the biology, diagnosis and host-pathogen interactions of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Establishment of functional B cell memory against parvovirus B19 capsid proteins may be associated with resolution of persistent infection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Aberrant cellular immune responses in humans infected persistently with parvovirus B19

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Direct ex vivo measurement of CD8(+) T-lymphocyte responses to human parvovirus B19.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Prolonged activation of virus-specific CD8+T cells after acute B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Tracking of peptide-specific CD4+ T-cell responses after an acute resolving viral infection: a study of parvovirus B19.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Sustained CD8+ T-cell responses induced after acute parvovirus B19 infection in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Enzyme-linked immunosorbent assay for IgG and IgM antibodies against human parvovirus B19: use of monoclonal antibodies and viral antigen propagated in vitro

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Identification of an immunodominant peptide in the parvovirus B19 VP1 unique region able to elicit a long-lasting immune response in humans

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19 infection: immunohistochemical and electron microscopic studies of skin lesions

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

The cutaneous manifestations of human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19 DNA in synovial fluid

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus infection after renal transplant.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 infection after transplantation: a review of 98 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Incidence and clinical significance of human parvovirus B19 infection in kidney transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Donor-transmitted parvovirus infection in a kidney transplant recipient presenting as pancytopenia and allograft dysfunction.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

B19 virus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Unusual incidence of aplastic anaemia due to B-19 parvovirus infection in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Recurrent anemia in kidney transplant recipients with parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Unusual bone marrow manifestations of parvovirus B19 infection in immunocompromised patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Glomerulonephritis associating parvovirus B19 infection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Characteristics of acute glomerulonephritis associated with human parvovirus B19 infection.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Nephrotic syndrome associated with human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Endocapillary proliferative glomerulonephritis in a patient with parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Association of parvovirus B19 infection with acute glomerulonephritis in healthy adults: case report and review of the literature.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Renal involvement induced by human parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Renal involvement of human parvovirus B19 in an immunocompetent host

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Glomerulonephritis after human parvovirus infection in homozygous sickle-cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus glomerulonephritis in a patient with sickle cell disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Treatment of parvovirus B-19 (PV B-19) infection allows for successful kidney transplantation without disease recurrence

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Concomitant parvovirus B19 and cytomegalovirus infections after living-related renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Renal anemia aggravated by long-term parvovirus B19 and cytomegalovirus infection in a renal transplant patient: case report and evaluation of B19 seroprevalence in dialysis patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Human parvovirus B19 infection in organ transplant recipients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Serologic and molecular detection of human Parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 Clearance from Peripheral Blood after Acute Infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Eradication of parvovirus B19 infection after renal transplantation requires reduction of immunosuppression and high-dose immunoglobulin therapy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Acute renal failure in a pediatric kidney allograft recipient treated with intravenous immunoglobulin for parvovirus B19 induced pure red cell aplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Acute renal failure in a renal allograft recipient treated with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Nephrotoxicity of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Discontinuation of immunosuppressive antimetabolite for parvovirus B19-associated anemia in kidney transplant patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 infection causing red cell aplasia in renal transplantation on tacrolimus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

A case of persistent anemia in a renal transplant recipient: association with parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Tacrolimus and pure red-cell aplasia

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19-induced anemia in renal transplantation: a role for rHuEPO in resistance to classical treatment

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus [correction of Parovirus] B19-induced red cell aplasia in solid-organ transplant recipients. Two case reports and review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Cytokine gene polymorphisms associated with symptomatic parvovirus B19 infection

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus-associated arthritis

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Pathogenesis of human parvovirus B19 in rheumatic disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Activation of synoviocytes by the secreted phospholipase A2 motif in the VP1-unique region of parvovirus B19 minor capsid protein

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 in pregnancy

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Serologic study of human parvovirus B19 infection in pregnancy in Japan

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19-related acute hepatitis in an immunosuppressed kidney transplant

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Fibrosing cholestatic hepatitis possibly related to persistent parvovirus B19 infection in a renal transplant recipient

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Severe parvovirus B19 encephalitis after renal transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Parvovirus B19 infection-related complications in renal transplant recipients: treatment with intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1038%2FNCPNEPH0609

7 January 2021

Identifiers

DOI

10.1038/NCPNEPH0609

1 reference

17 August 2017

1 reference